Literature DB >> 10528957

Clinical information for research; the use of general practice databases.

R Lawrenson1, T Williams, R Farmer.   

Abstract

General practice computers have been widely used in the United Kingdom for the last 10 years and there are over 30 different systems currently available. The commercially available databases are based on two of the most widely used systems--VAMP Medical and Meditel. These databases provide both longitudinal and cross-sectional data on between 1.8 and 4 million patients. Despite their availability only limited use has been made of them for epidemiological and health service research purposes. They are a unique source of population-based information and deserve to be better recognized. The advantages of general practice databases include the fact that they are population based with excellent prescribing data linked to diagnosis, age and gender. The problems are that their primary purpose is patient care and the database population is constantly changing, as well as the usual problems of bias and confounding that occur in any observational studies. The barriers to the use of general practice databases include the cost of access, the size of the databases and that they are not structured in a way that easily allows analysis. Proper utilization of these databases requires powerful computers, staff proficient in writing computer programs to facilitate analysis and epidemiologists skilled in their use. If these structural problems are overcome then the databases are an invaluable source of data for epidemiological studies.

Entities:  

Mesh:

Year:  1999        PMID: 10528957     DOI: 10.1093/pubmed/21.3.299

Source DB:  PubMed          Journal:  J Public Health Med        ISSN: 0957-4832


  83 in total

Review 1.  The general practice research database: role in pharmacovigilance.

Authors:  Louise Wood; Carlos Martinez
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Prediagnostic use of low-dose aspirin and risk of incident metastasis and all-cause mortality among patients with colorectal cancer.

Authors:  Giovanni Giorli; Julie Rouette; Hui Yin; Francesco Lapi; Monica Simonetti; Claudio Cricelli; Michael Pollak; Laurent Azoulay
Journal:  Br J Clin Pharmacol       Date:  2020-05-14       Impact factor: 4.335

3.  Non-steroidal anti-inflammatory drugs and the risk of Clostridium difficile-associated disease.

Authors:  Daniel Suissa; Joseph A C Delaney; Sandra Dial; Paul Brassard
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

4.  Utility of routinely acquired primary care data for paediatric disease epidemiology and pharmacoepidemiology.

Authors:  Peter J Helms; Suzie Ekins Daukes; Michael W Taylor; Colin R Simpson; James S McLay
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

5.  Interaction risk with proton pump inhibitors in general practice: significant disagreement between different drug-related information sources.

Authors:  Gianluca Trifirò; Salvatore Corrao; Marianna Alacqua; Salvatore Moretti; Michele Tari; Achille P Caputi; Vincenzo Arcoraci
Journal:  Br J Clin Pharmacol       Date:  2006-07-06       Impact factor: 4.335

6.  Evidence-Based Knowledge Management: an approach to effectively promote good health-care decision-making in the Information Era.

Authors:  Salvatore Corrao; Vincenzo Arcoraci; Sabrina Arnone; Luigi Calvo; Rosario Scaglione; Cristofaro Di Bernardo; Roberto Lagalla; Achille Patrizio Caputi; Giuseppe Licata
Journal:  Intern Emerg Med       Date:  2008-08-16       Impact factor: 3.397

7.  An increase in the prevalence of type 1 and 2 diabetes in children and adolescents: results from prescription data from a UK general practice database.

Authors:  Yingfen Hsia; Antje C Neubert; Fariz Rani; Russell M Viner; Peter C Hindmarsh; Ian C K Wong
Journal:  Br J Clin Pharmacol       Date:  2009-02       Impact factor: 4.335

8.  Ongoing challenges in pharmacovigilance.

Authors:  Gerald J Dal Pan
Journal:  Drug Saf       Date:  2014-01       Impact factor: 5.606

9.  Association of practice size and pay-for-performance incentives with the quality of diabetes management in primary care.

Authors:  Eszter P Vamos; Utz J Pape; Alex Bottle; Fiona Louise Hamilton; Vasa Curcin; Anthea Ng; Mariam Molokhia; Josip Car; Azeem Majeed; Christopher Millett
Journal:  CMAJ       Date:  2011-08-02       Impact factor: 8.262

10.  Estimated GFR reporting is not sufficient to allow detection of chronic kidney disease in an Italian regional hospital.

Authors:  Giorgio Gentile; Maurizio Postorino; Raymond D Mooring; Luigi De Angelis; Valeria Maria Manfreda; Fabrizio Ruffini; Manuela Pioppo; Giuseppe Quintaliani
Journal:  BMC Nephrol       Date:  2009-09-01       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.